Lawrence Einhorn | |
---|---|
Alma mater | |
Scientific career | |
Institutions |
Lawrence Einhorn is an American oncologist at Indiana University School of Medicine. [1] A pioneer in cancer treatment research, Einhorn developed cisplatin-based chemotherapy regimens that increased cure rates while minimizing toxic side effects. [2] [3]
This section of a biography of a living person needs additional citations for verification .(November 2018) |
Einhorn received a B.S. from Indiana University Bloomington in 1965 and his M.D. from the University of Iowa in 1968. He served his internship and residency at Indiana University Medical Center, followed by a fellowship in Hematology/Oncology at the M.D. Anderson Hospital Tumor Institute in Houston, Texas. He returned to IU Medical Center in 1973 and was named Distinguished Professor of Medicine in 1987. He became the first Lance Armstrong Foundation Professor of Oncology in 2006. [3] Einhorn is also a member of the Experimental and Developmental Therapeutics Program at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center in Indianapolis.
Einhorn has received numerous honors in his career including the Glenn Irwin Experience Excellence Award, Riley Distinguished Lecturer, the Kettering Prize Cancer Research-General Motors Foundation, the ACCC Clinical Oncology Award, the Distinguished Clinician Award from the Milken Foundation, the Willis Stetson Award and Lecture from The University of Pennsylvania, the Richard and Hinda Rosenthal Foundation Award for Cancer Research, the Herman B Wells Visionary Award, the State of Israel Peace Medal, the Vermeil Medal of Paris, and The David A. Kamofsky Memorial Award and Lecture from the American Society of Clinical Oncology. [4] He was elected to membership in the National Academy of Sciences and American Philosophical Society in 2001.
Testicular cancer is cancer that develops in the testicles, a part of the male reproductive system. Symptoms may include a lump in the testicle or swelling or pain in the scrotum. Treatment may result in infertility.
Choriocarcinoma is a malignant, trophoblastic cancer, usually of the placenta. It is characterized by early hematogenous spread to the lungs. It belongs to the malignant end of the spectrum in gestational trophoblastic disease (GTD). It is also classified as a germ cell tumor and may arise in the testis or ovary.
A dysgerminoma is a type of germ cell tumor; it usually is malignant and usually occurs in the ovary.
Germ cell tumor (GCT) is a neoplasm derived from the primordial germ cells. Germ-cell tumors can be cancerous or benign. Germ cells normally occur inside the gonads. GCTs that originate outside the gonads may be birth defects resulting from errors during development of the embryo.
A seminoma is a germ cell tumor of the testicle or, more rarely, the mediastinum or other extra-gonadal locations. It is a malignant neoplasm and is one of the most treatable and curable cancers, with a survival rate above 95% if discovered in early stages.
Adjuvant therapy, also known as adjunct therapy, adjuvant care, or augmentation therapy, is a therapy that is given in addition to the primary or initial therapy to maximize its effectiveness. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments. An example of such adjuvant therapy is the additional treatment usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due to the presence of undetected disease. If known disease is left behind following surgery, then further treatment is not technically adjuvant.
A mediastinal tumor is a tumor in the mediastinum, the cavity that separates the lungs from the rest of the chest. It contains the heart, esophagus, trachea, thymus, and aorta. The most common mediastinal masses are neurogenic tumors, usually found in the posterior mediastinum, followed by thymoma (15–20%) located in the anterior mediastinum. Lung cancer typically spreads to the lymph nodes in the mediastinum.
Retroperitoneal lymph node dissection (RPLND) is a surgical procedure to remove abdominal lymph nodes. It is used to treat testicular cancer, as well as to help establish the exact stage and type of the cancer.
A germinoma is a type of germ-cell tumor, which is not differentiated upon examination. It may be benign or malignant.
Mediastinal germ cell tumors are tumors that derive from germ cell rest remnants in the mediastinum. Germ cell tumors most commonly occur in the gonad but occasionally elsewhere.
It's Not About the Bike: My Journey Back to Life is a 2000 autobiographical book by American cyclist Lance Armstrong with Sally Jenkins.
Emil J. Freireich was an American hematologist, oncologist, and cancer biologist. He was recognized as a pioneer in the treatment of cancer and use of chemotherapy and is often known as the father of modern leukemia therapy.
Germ cell neoplasia in situ (GCNIS) represents the precursor lesion for many types of testicular germ cell tumors.
John P. Donohue was an American physician. He was the Chairman of the Urology Department and Distinguished Professor Emeritus at Indiana University School of Medicine. He pioneered treatments for testicular cancer, including the nerve-sparing technique. His work with Dr. Lawrence Einhorn led to an increase in cure rate of testicular cancer from 5% to 90%. He studied under Wyland F. Leadbetter. He began his career as a United States Navy officer while serving as the ship's surgeon aboard the aircraft carrier USS Wasp.
Orchiectomy is a surgical procedure in which one or both testicles are removed. The surgery can be performed for various reasons:
Endodermal sinus tumor (EST) is a member of the germ cell tumor group of cancers. It is the most common testicular tumor in children under three, and is also known as infantile embryonal carcinoma. This age group has a very good prognosis. In contrast to the pure form typical of infants, adult endodermal sinus tumors are often found in combination with other kinds of germ cell tumor, particularly teratoma and embryonal carcinoma. While pure teratoma is usually benign, endodermal sinus tumor is malignant.
George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015. In 2019, he was named Memorial Sloan Kettering's first ombudsperson.
An extracranial germ cell tumor (EGCT) occurs in the abnormal growth of germ cells in the gonads and the areas other than the brain via tissue, lymphatic system, or circulatory system. The tumor can be benign or malignant (cancerous) by its growth rate. According to the National Cancer Institute and St. Jude Children's Research Hospital, the chance of children who are under 15 years old having EGCTs is 3%, in comparison to adolescents, a possibility of 14% with aged 15 to 19 can have EGCTs. There is no obvious cut point in between children and adolescents. However, common cut points in researches are 11 years old and 15 years old.
Patrick J. Loehrer is an American oncologist who is Indiana University Distinguished Professor, Joseph W. and Jackie J. Cusick Professor in Oncology, Professor of medicine, Indiana University School of Medicine; Director emeritus, Indiana University Melvin and Bren Simon Comprehensive Cancer Center.